Magdalena A. Benda

Triesen, 9495, Liechtenstein

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic review.

Infectious toxicities associated with bispecific antibodies and CAR-T Cells in multiple myeloma: a systematic review.

Journal: Annals of hematology
Published: May 04, 2026

Continuous ventilation versus 30:2 strategy in mechanical cardiopulmonary resuscitation - a manikin-based simulation study.

Continuous ventilation versus 30:2 strategy in mechanical cardiopulmonary resuscitation - a manikin-based simulation study.

Journal: BMC emergency medicine
Published: July 12, 2025

Exploring the impact of first-line durvalumab plus chemotherapy on advanced biliary tract cancer: a systematic review and meta-analysis.

Exploring the impact of first-line durvalumab plus chemotherapy on advanced biliary tract cancer: a systematic review and meta-analysis.

Journal: The oncologist
Published: April 15, 2025

Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q.

Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q.

Journal: Cancers
Published: February 20, 2025

Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.

Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data.

Journal: Cancer immunology, immunotherapy : CII
Published: August 01, 2024

Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies.

Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies.

Journal: Annals of hematology
Published: November 20, 2023

Attrition Rates in Multiple Myeloma Treatment under Real World Conditions-An Analysis from the Austrian Myeloma Registry (AMR).

Attrition Rates in Multiple Myeloma Treatment under Real World Conditions-An Analysis from the Austrian Myeloma Registry (AMR).

Journal: Cancers
Published: December 26, 2022

SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.

SARS-CoV-2 RBD-specific and NP-specific antibody response of healthcare workers in the westernmost Austrian state Vorarlberg: a prospective cohort study.

Journal: BMJ open
Published: May 25, 2022

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response.

Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response.

Journal: British journal of haematology
Published: October 23, 2021

Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients.

Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients.

Journal: British journal of haematology
Published: June 07, 2021

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.

Journal: Frontiers in immunology
Published: May 03, 2021
Showing 1-11 of 11

Last Updated: 09/26/2026